Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

SAVASAVA

Showing 8 of 28 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in FILANA THERAPEUTICS INC

Yes. Jane Street Group holds 58,981 shares of SAVA (Filana Therapeutics), worth $70,187, as of its Q2 2026 13F filing. It reduced the position by 166,183 shares (-73.8%) from Q1 2026. Jane Street Group has held SAVA since Q3 2019, across 28 quarterly 13F filings.

Current Value

$70,187

Current Shares

58,981

Total Value Change

-$2.2M

Total Shares Change

-17,952

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
58,981
-73.8%
$70,1870.0%$1.19
0
2026-Q1
Decreased
225,164
-56.1%
$380,5280.0%$1.69
0
2025-Q4
Increased
513,137
+162.4%
$1M0.0%$1.98
40
2025-Q3
Decreased
195,571
-42.2%
$569,1110.0%$2.91
0
2025-Q2
Increased
338,600
+22.3%
$612,8660.0%$1.81
29
2025-Q1
Decreased
276,835
-30.8%
$415,2530.0%$1.50
0
2024-Q4
Increased
400,239
+420.2%
$944,5640.0%$2.36
40
2024-Q3
Decreased
76,933
-36.0%
$2.3M0.0%$29.43
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used